Tine Carmeliet
Senior Associate
Brussels
Tine Carmeliet
Senior Associate
Brussels
Contact details
Tine is a Senior Associate in Allen & Overy's Life Sciences Practice.
She specializes in life sciences patents litigation and advises clients on regulatory issues and commercial transactions in the life science sector. Her litigation experience includes both representing clients before the Belgian and European courts and assisting clients with multi-jurisdictional proceedings.
She advices multinational companies and start-ups as well as research institutes in the pharmaceutical, biotech and medical devices sectors on a variety of complex matters, including clinical trials, product approvals, regulatory incentives, market access, promotion and advertising, post-market obligations, MDR and IVDR, digital health solutions, artificial intelligence, real world data and transparency regulations. She regularly assists clients with drafting and negotiating high value IP licenses, R&D collaborations, tech transfer and spin-out deals and has particular expertise with cell and gene therapy products.
In addition, Tine has extensive experience advising on agro(bio)tech and food and feed regulations (new breeding techniques and Nagoya Protocol).
She also has a sound life sciences policy understanding thanks to her secondment to the European Federation of Pharmaceutical Industries Associations legal team, where she focused on regulatory and IP policy.
Qualifications
Academic
LLM, University of Leuven, 2013
Master of Arts, The Johns Hopkins University Paul H. Nitze School of Advanced International Studies, 2015
Related articles
Blog Post: 05 October 2023
Companion diagnostics are classed in the U.S. and in the EU as medical devices, usually in-vitro medical devices (IVDs).
Blog Post: 07 September 2023
Commission proposal for a new European legal framework for GMOs
Blog Post: 06 September 2023
Qualifications
Academic
LLM, University of Leuven, 2013
Master of Arts, The Johns Hopkins University Paul H. Nitze School of Advanced International Studies, 2015
Awards & accolades
Trailblazer in most influential women in IP
World Intellectual Property Review (2020)
Regulatory rising star
LMG Life Sciences EMEA
Rising star leading practitioner
Euromoney PLC
Published work
- CARMELIET, T., VAN ESPEN, L., “ Astrazeneca ordered to deliver vaccines to the EU” (ed. Lawtext Publishing Limited), Bio-Science Law Review, Volume 18, Issue 2, September 2021, Page 57
- CARMELIET, T., VAN DYCK, P., "It’s time to amend the Enforcement Directive to ensure all EU Member States provide for declarations of non-infringement of EUTMs and Community designs." (ed. STONE, D. & POTTS, B.), Journal of Intellectual Property Law & Practice, Volume 14, Issue 10, October 2019, Pages 754–760
- CARMELIET, “The Gx contribution to multilateral trade governance: balancing efficiency and inclusiveness”, Hart Publishing, 2018.
- G. GLAS and T. CARMELIET, “The European Court of Justice to rule on milestone in European GMO legislation: the legal classification of mutagenesis in plant breeding”, the Bioscience Law Review 2017, Volume 16, Issue 2, Page 91.
- E. VAN KEYMEULEN and T. CARMELIET, ““Sunshine” in Belgium: new statutory transparency requirements for life sciences companies”, European Pharmaceutical Law Review 2017, Pages 26-31.
- T. CARMELIET AND G. KOSMIDOU, “Enforcing Europe’s Foundational Values. Central and Eastern Europe: A Case in Point”, European Judicial Systems as a Challenge for Democracy, Intersentia, Antwerp, 2015.
- T. CARMELIET, “A Critical Analysis of the Procedural Fairness of the Leniency Instrument. Finding the Right Balance Between Efficiency and Justice in EU Competition Law”, Jura Falconis 2013-2014, Page 2.
